Ceragenix preclinical data

In mice infected with vaccinia virus, topical CSA-13 significantly reduced the mean number of satellite lesions at day 8 vs. control (0.7 vs. 2.5 lesions, p<0.05) and at day 10 (4.5 vs. 9.3 lesions, p...